Literature DB >> 11549651

Dynamics of inhibin subunit and follistatin mRNA during development of normal and polycystic ovary syndrome follicles.

T Fujiwara1, Y Sidis, C Welt, G Lambert-Messerlian, J Fox, A Taylor, A Schneyer.   

Abstract

To further explore the developmental dynamics and possible roles of inhibin, activin, and follistatin in the development of human antral follicles as well as the relationship between mRNA and protein levels of these hormones within follicles, quantitative competitive RT-PCR assays were established to determine mRNA levels for the inhibin/activin subunits and both follistatin splice variants. Granulosa cell RNA was obtained by transvaginally aspirating follicles (6-23 mm) from carefully characterized normal women at different times of the follicular phase. alpha- and beta(A)-subunit mRNA levels increased significantly with follicle diameter (r = 0.56; P < 0.01 and r = 0.45; P < 0.05, respectively) and follicle maturity (r = 0.65; P < 0.001 and r = 0.58; P < 0.01, respectively), but beta(B) mRNA levels, which were at least 10-fold lower than levels of the other subunits, showed no relationship to size or maturity. Both follistatin 315 and 288 transcripts were detected in granulosa cells, but neither follistatin transcript varied significantly across the range of follicle sizes analyzed. In addition, granulosa cells contained three follistatin 315 mRNA transcripts for each follistatin 288 transcript, and the follistatin 315/288 ratio did not vary with follicle size. alpha-Subunit mRNA levels were positively associated with dimeric inhibin A protein in human follicular fluid from the same follicle aspirates (r = 0.71; P < 0.001). Similarly, beta(A)-subunit mRNA was associated with inhibin A (r = 0.59; P < 0.01), and beta(B) mRNA was associated with inhibin B (r = 0.67; P < 0.005) in these samples. Thus, the increase in inhibin subunit transcription and protein synthesis with follicle size suggests that inhibin biosynthesis might be important for continued development of the dominant follicle. To explore this hypothesis further, we compared mRNA levels for each of these transcripts in follicles obtained from six polycystic ovary syndrome patients (eight follicles) and compared the results to those from a group (n = 5) of normal follicles matched for mean diameter. Comparisons were also performed for a subset of polycystic ovary syndrome follicles (n = 5) matched for diameter and size range with the normal group. alpha-Subunit mRNA levels were 16-fold lower in both polycystic ovary syndrome follicle groups relative to size-matched normal follicles (P < 0.02), whereas beta(A)-subunit mRNA was significantly lower only when all polycystic ovary syndrome follicles were compared. beta(B)-Subunit and follistatin mRNA levels and the follistatin 315/288 ratio were not statistically different for any group. These results suggest that insufficient production of inhibin alpha and possibly beta(A)-subunits, but not follistatin, is associated with follicular arrest in polycystic ovary syndrome follicles.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11549651     DOI: 10.1210/jcem.86.9.7798

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

1.  Luteal-phase inhibin A and follicular-phase inhibin B levels are not characteristic of patients with an elevated LH-to-FSH ratio.

Authors:  Erik E Hauzman; Péter Fancsovits; Akos Murber; Thomas Rabe; Thomas Strowitzki; Zoltán Papp; János Urbancsek
Journal:  J Assist Reprod Genet       Date:  2006-03       Impact factor: 3.412

Review 2.  Inhibin at 90: from discovery to clinical application, a historical review.

Authors:  Yogeshwar Makanji; Jie Zhu; Rama Mishra; Chris Holmquist; Winifred P S Wong; Neena B Schwartz; Kelly E Mayo; Teresa K Woodruff
Journal:  Endocr Rev       Date:  2014-07-22       Impact factor: 19.871

Review 3.  Developmental origin of reproductive and metabolic dysfunctions: androgenic versus estrogenic reprogramming.

Authors:  Vasantha Padmanabhan; Almudena Veiga-Lopez
Journal:  Semin Reprod Med       Date:  2011-06-27       Impact factor: 1.303

4.  Circulating follistatin displays a day-night rhythm and is associated with muscle mass and circulating leptin levels in healthy, young humans.

Authors:  Athanasios D Anastasilakis; Stergios A Polyzos; Elpida C Skouvaklidou; Georgios Kynigopoulos; Zacharias G Saridakis; Aggeliki Apostolou; Georgios A Triantafyllou; Thomai Karagiozoglou-Lampoudi; Christos S Mantzoros
Journal:  Metabolism       Date:  2016-07-08       Impact factor: 8.694

Review 5.  Ontogeny of the ovary in polycystic ovary syndrome.

Authors:  Daniel A Dumesic; Joanne S Richards
Journal:  Fertil Steril       Date:  2013-03-06       Impact factor: 7.329

Review 6.  Animal models of the polycystic ovary syndrome phenotype.

Authors:  Vasantha Padmanabhan; Almudena Veiga-Lopez
Journal:  Steroids       Date:  2013-05-20       Impact factor: 2.668

7.  Developmental Programming: Sheep Granulosa and Theca Cell-Specific Transcriptional Regulation by Prenatal Testosterone.

Authors:  Muraly Puttabyatappa; Xingzi Guo; John Dou; Daniel Dumesic; Kelly M Bakulski; Vasantha Padmanabhan
Journal:  Endocrinology       Date:  2020-08-01       Impact factor: 4.736

8.  Female infertility and disrupted angiogenesis are actions of specific follistatin isoforms.

Authors:  Shyr-Yeu Lin; Rebecca G Craythorn; Anne E O'Connor; Martin M Matzuk; Jane E Girling; John R Morrison; David M de Kretser
Journal:  Mol Endocrinol       Date:  2007-10-11

9.  Intrafollicular Concentrations of the Oocyte-secreted Factors GDF9 and BMP15 Vary Inversely in Polycystic Ovaries.

Authors:  Stine Gry Kristensen; Ajay Kumar; Linn Salto Mamsen; Bhanu Kalra; Susanne Elisabeth Pors; Jane Alrø Bøtkjær; Kirsten Tryde Macklon; Jens Fedder; Erik Ernst; Kate Hardy; Stephen Franks; Claus Yding Andersen
Journal:  J Clin Endocrinol Metab       Date:  2022-07-14       Impact factor: 6.134

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.